Based on the Japan Lifeline Co Ltd stock forecast from 0 analysts, the average analyst target price for Japan Lifeline Co Ltd is not available over the next 12 months. Japan Lifeline Co Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Japan Lifeline Co Ltd is Slightly Bullish , which is based on 10 positive signals and 5 negative signals. At the last closing, Japan Lifeline Co Ltd’s stock price was JPY 1,333.00. Japan Lifeline Co Ltd’s stock price has changed by -1.19% over the past week, +5.46% over the past month and +10.35% over the last year.
No recent analyst target price found for Japan Lifeline Co Ltd
No recent average analyst rating found for Japan Lifeline Co Ltd
Company Overview Japan Lifeline Co Ltd
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems; and coronary and peripheral intervention products include PTCA and PTA guide wires, and PTCA balloon catheters. In addition, the company offers gastrointestinal intervention products that cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems; structural heart disease intervention products, such as radiofrequency wires and atrial septal defect closure devices; and neurovascular intervention products. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan. Read Less
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcu...Read More
Frequently Asked Questions About Japan Lifeline Co Ltd (7575:TSE) Stock
Stock Target Advisor's fundamental analysis for Japan Lifeline Co Ltd's stock is Slightly Bullish .
7575:TSE stock's dividend yield is 7.10%.
Our analysis grades 7575:TSE stock's dividend yield at B. This means that 7575:TSE stock's dividend yield is above 85% of the stocks in the Medical Devices sector in the TSE exchange.
Based on this 7575:TSE may be a good dividend stock for its sector.
Unfortunately we do not have enough data on 7575:TSE's stock to indicate what its average analyst target is.
7575:TSE stock's Price/Earning ratio is 11.94.
Our analysis grades 7575:TSE stock's Price / Earning ratio at B-. This means that 7575:TSE stock's Price/Earning ratio is above 18% of the stocks in the Medical Devices sector in the TSE exchange.
Based on this 7575:TSE may be undervalued for its sector.
The last closing price of 7575:TSE's stock was JPY 1,333.00.
The most recent market capitalization for 7575:TSE is JPY 90.57B.
Unfortunately we do not have enough analyst data on 7575:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Japan Lifeline Co Ltd's stock.
As per our most recent records Japan Lifeline Co Ltd has 1,216 Employees.
Japan Lifeline Co Ltd's registered address is Tennoz Ocean Square, Tokyo, Japan, 140-0002.
You can get more information about it from Japan Lifeline Co Ltd's website at https://www.japanlifeline.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Japan Lifeline Co Ltd (7575:TSE) Stock
Stock Target Advisor's fundamental analysis for Japan Lifeline Co Ltd's stock is Slightly Bullish .
7575:TSE stock's dividend yield is 7.10%.
Our analysis grades 7575:TSE stock's dividend yield at B. This means that 7575:TSE stock's dividend yield is above 85% of the stocks in the Medical Devices sector in the TSE exchange.
Based on this 7575:TSE may be a good dividend stock for its sector.
Unfortunately we do not have enough data on 7575:TSE's stock to indicate what its average analyst target is.
7575:TSE stock's Price/Earning ratio is 11.94.
Our analysis grades 7575:TSE stock's Price / Earning ratio at B-. This means that 7575:TSE stock's Price/Earning ratio is above 18% of the stocks in the Medical Devices sector in the TSE exchange.
Based on this 7575:TSE may be undervalued for its sector.
The last closing price of 7575:TSE's stock was JPY 1,333.00.
The most recent market capitalization for 7575:TSE is JPY 90.57B.
Unfortunately we do not have enough analyst data on 7575:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Japan Lifeline Co Ltd's stock.
As per our most recent records Japan Lifeline Co Ltd has 1,216 Employees.
Japan Lifeline Co Ltd's registered address is Tennoz Ocean Square, Tokyo, Japan, 140-0002.
You can get more information about it from Japan Lifeline Co Ltd's website at https://www.japanlifeline.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 7575:TSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
